Auldyn Hirschey
Adult Health · Baton Rouge, LANPI 1114176914
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,698 of the $5,912 with a category attached, or 62.6%. 42 manufacturers reported payments, led by Novartis at 41.2% of the total. 2025 is the largest year on record at $1,871, 9.2 times the $203 reported in 2021.
Across 149 payments — averaging $39.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Exelixis Inc.$1K
- Bristol Myers Squibb$270
- Johnson & Johnson$264
- AstraZeneca$159
- Pfizer$148
- plus $1K from 36 others
What the payments were for
- Food & beverage$3,69863%
- Education$1002%
- Other$2,11536%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,912 in reported general payments places this provider in the 85th percentile of 203 adult health providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 14 | $10,523 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 98 | $1,921 |
| Ondansetron OdtOndansetron | 150 | $1,681 |
| Famciclovir | 38 | $1,503 |
| Dexamethasone | 37 | $811 |
| Morphine Sulfate ErMorphine Sulfate | 22 | $542 |
| Mirtazapine | 26 | $538 |
| Promethazine Hcl | 74 | $511 |
| Pantoprazole Sodium | 58 | $424 |
| Anastrozole | 27 | $398 |
| Levothyroxine Sodium | 58 | $396 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 27 | $360 |
| Tamoxifen Citrate | 15 | $349 |
| Tamsulosin Hcl | 17 | $295 |
| Prednisone | 54 | $273 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $148 | $10,52314 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 203 adult health providers in Louisiana.
Other adult health in Baton Rouge
- Joan SmithBaton Rouge$121K
- Deborah SmithBaton Rouge$18K
- Tanisha SmithBaton Rouge$17K
- Eva Marina StaffordBaton Rouge$15K
- Dustin DenicolaBaton Rouge$14K
- Wendy GillBaton Rouge$13K
- Jennifer LeblancBaton Rouge$12K
- Carrie PerryBaton Rouge$6K
- Colette BlanchardBaton Rouge$6K
- Stephanie AkunneBaton Rouge$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.